
Alliance Pharma has agreed to a £349.7 million pound takeover by DBAY Advisors, its biggest shareholder.
The deal would see shareholders get 62.5p per share, representing a 41% uplift on Alliance Pharma’s closing share price of 44.35p on Thursday.

Alliance Pharma has agreed to a £349.7 million pound takeover by DBAY Advisors, its biggest shareholder.
The deal would see shareholders get 62.5p per share, representing a 41% uplift on Alliance Pharma’s closing share price of 44.35p on Thursday.